Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-08-31 16942
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 384
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 387
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2017-10-11 2018-01-23 25292
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-24 2020-08-17 118766
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-09-20 138960

Showing 1801 to 1820 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-TRAZODONE TABLETS 100MG 100MG TABLET Discontinued 2018-09-08 2018-09-15 60831
APO-TRAZODONE TABLETS 50MG 50MG TABLET Discontinued 2018-09-08 2018-09-15 60834
APO-VALACYCLOVIR 500MG TABLET Discontinued 2018-09-08 2018-09-15 60840
APO-VALGANCICLOVIR 450MG TABLET Discontinued 2018-09-08 2018-09-15 60843
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057

Showing 321 to 340 of 359